MAEGHAN DAVIS: Open Payments
NPI 1053653824 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 14 payments from 7 companies in 2025. Trend: 2023 $558 · 2024 $354 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Indivior Inc. | 2 | $56 |
| Alkermes, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: SPRAVATO, SUBLOCADE, ABILIFY ASIMTUFII, ABILIFY MAINTENA, Qelbree, ARISTADA, FANAPT, UZEDY.
Industry payments across LA — which companies pay providers there.
